Catalysts for Caprelsa
19 tracked
Jan 27, 2026
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Sep 23, 2025
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 26, 2025
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
May 14, 2025
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Mar 7, 2024
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Apr 13, 2023
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Mar 28, 2022
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 15, 2020
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 5, 2020
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Oct 12, 2018
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
May 16, 2017
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Feb 24, 2017
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jul 28, 2016
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Mar 31, 2014
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Nov 27, 2013
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jul 3, 2013
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Oct 9, 2012
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Jun 22, 2011
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→
Apr 6, 2011
approval
CAPRELSA (VANDETANIB) — FDA approval
vandetanib
→